Journal article icon

Journal article

Targeting vascular endothelial growth factor in renal cell carcinoma.

Abstract:

Renal cancer is the most lethal of all urological malignancies with overall 5-year survival rates of around 60%. The predominant reason for the poor prognosis of this cancer has been the relative lack of effective systemic therapy for advanced metastatic disease. Until recently immunotherapy with interleukin-2 or interferon-alpha has been the standard of care for metastatic renal cell carcinoma (RCC); however, the response rates for these treatments were at best only 3-21%. The use of molecul...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1159/000260241

Authors


Journal:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Volume:
30
Issue:
5-6
Pages:
292-299
Publication date:
2009-01-01
DOI:
EISSN:
1423-0380
ISSN:
1010-4283
Source identifiers:
315972

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP